Needham says Cytokinetics' appeal as M&A target enhanced by HCM data
https://seekingalpha.com/news/4051040-needham-says-cytokinetics-appeal-as-ma-target-enhanced-by-hcm-data?source=feed_sector_healthcare
Dec 28, 2023 - Cytokinetics' (CYTK) attractiveness as a takeover target has been enhanced by positive data for its hypertrophic cardiomyopathy drug aficamten, according to Needham.
0
Big M&A and Bob Iger's future: 13 media executives make their anonymous 2024 predictions
https://www.cnbc.com/2023/12/20/13-media-executives-make-2024-predictions.html
Dec 21, 2023 - It's the third annual anonymous media predictions list: 13 media, sports and entertainment executives make their best 2024 industry-shaking predictions.
0
Company News for Dec 12, 2023
https://www.zacks.com/stock/news/2196623/company-news-for-dec-12-2023?cid=CS-ZC-FT-corporate_summary-2196623
Dec 12, 2023 - Companies In The News Are: M, CI, HUM, OXY, HAS.
0
J.M. Smucker Q2 Profit Up, Tops Estimates; Cuts FY24 Outlook; Stock Up In Premarket
https://www.rttnews.com/story.aspx?Id=3409567
Dec 05, 2023 - J. M. Smucker Co. (SJM), a maker of food and beverage products, reported Tuesday that its second-quarter net income grew 2 percent to $194.9 million from last year's $191.1 million.
0